Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Emergent Biosolutions Inc (NYSE: EBS) was $8.75 for the day, up 3.55% from the previous closing price of $8.45. In other words, the price has increased by $3.55 from its previous closing price. On the day, 1.26 million shares were traded. EBS stock price reached its highest trading level at $9.06 during the session, while it also had its lowest trading level at $8.44.
Ratios:
Our analysis of EBS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.57. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 2.27 whereas as Long-Term Debt/Eq ratio is at 1.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $16.
On March 07, 2024, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 04 ’24 when Zoon Kathryn C sold 10,000 shares for $6.11 per share. The transaction valued at 61,100 led to the insider holds 54,482 shares of the business.
Zoon Kathryn C sold 1,830 shares of EBS for $8,436 on May 29 ’24. The Director now owns 64,482 shares after completing the transaction at $4.61 per share. On May 21 ’24, another insider, Zoon Kathryn C, who serves as the Director of the company, sold 1,089 shares for $5.78 each. As a result, the insider received 6,294 and left with 48,882 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 462932736 and an Enterprise Value of 1270032896. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43 while its Price-to-Book (P/B) ratio in mrq is 1.20. Its current Enterprise Value per Revenue stands at 1.152 whereas that against EBITDA is -16.016.
Stock Price History:
Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 6.17%, while the 200-Day Moving Average is calculated to be 62.31%.
Shares Statistics:
EBS traded an average of 3.01M shares per day over the past three months and 1611510 shares per day over the past ten days. A total of 52.20M shares are outstanding, with a floating share count of 51.92M. Insiders hold about 3.89% of the company’s shares, while institutions hold 56.45% stake in the company. Shares short for EBS as of 1727654400 were 8229525 with a Short Ratio of 2.73, compared to 1724976000 on 3837173. Therefore, it implies a Short% of Shares Outstanding of 8229525 and a Short% of Float of 19.0.
